Virtual Reality Gaming for Neuropathic Pain
(VRWalk Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if playing a virtual reality walking game can reduce neuropathic pain in people with chronic spinal cord injuries. Participants will play one of two different VR games, VR Game 1 or VR Game 2, twice daily for ten days. The trial seeks adults who have experienced persistent, daily pain for at least three months and have stable pain medication. Participants should not have severe motion sickness and must have mobile connectivity. This trial may suit those with a spinal injury at the lower neck or back, sustained for over a year. As an unphased trial, it offers a unique opportunity to explore innovative pain relief methods through virtual reality.
Will I have to stop taking my current medications?
The trial requires that you have been stable on your pain medication for at least one month, so you will not need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that using virtual reality (VR) games for nerve pain is generally safe. Studies have found that VR games, such as VR Game 1 and VR Game 2, can help manage pain in people with spinal cord injuries. Most participants handle the treatment well. Some studies noted that a few individuals might experience dizziness or nausea, similar to motion sickness, from the game. However, no major safety concerns have been reported. This indicates that the VR games are mostly well-tolerated by those who try them.12345
Why are researchers excited about this trial's treatments?
Researchers are excited about using virtual reality (VR) games for neuropathic pain because these treatments offer a non-invasive and drug-free alternative to traditional pain management methods like medications or physical therapy. Unlike standard treatments that may involve opioids or other drugs with potential side effects, VR games provide an innovative approach by engaging patients in immersive environments that can distract from pain and potentially retrain the brain's response to pain signals. Additionally, VR games can be customized and scaled for individual needs, offering a personalized experience that standard treatments may not provide. This approach not only aims to reduce pain effectively but also improves the overall patient experience by making treatment more engaging and enjoyable.
What evidence suggests that this trial's virtual reality games could be effective for neuropathic pain?
This trial will compare two virtual reality (VR) games for managing neuropathic pain. Studies have shown that VR Game 1 can significantly reduce nerve pain, with a 42-point drop on a 0–100 scale. Similarly, VR Game 2 has shown a positive and measurable impact, with an effect size of 0.31. Both VR games have demonstrated promise in helping manage pain for people with spinal cord injuries.13467
Who Is on the Research Team?
Zina Trost, PhD
Principal Investigator
Texas A&M University
Are You a Good Fit for This Trial?
This trial is for adults over 18 with chronic spinal cord injury who have been experiencing significant neuropathic pain daily for at least three months. Participants should be stable on pain medication, able to move their elbows, and have a compatible mobile device. Those with motion sickness affecting daily life or blindness cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants play a virtual reality game twice a day for 10 days
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- VR Game 1
- VR Game 2
Find a Clinic Near You
Who Is Running the Clinical Trial?
Texas A&M University
Lead Sponsor
Virginia Commonwealth University
Lead Sponsor
McGuire Veterans Hospital
Collaborator
Immersive Experience Labs
Collaborator
Richmond VA Medical Center
Collaborator
United States Department of Defense
Collaborator